Spaulding Rehabilitation Hospital

PathMaker Neurosystems Announces Initiation of First-in-Human Trial in ALS for Non-Invasive Neuromodulation Device

Retrieved on: 
Thursday, September 14, 2023
Spaulding Rehabilitation Hospital, Muscular Dystrophy Association, Physical medicine and rehabilitation, CERF, Clinical trial, DSM-IV codes, Associate, Bangladesh Technical Education Board, Rehabilitation, Faculty, EFS, Healey, Entrepreneurship, Hospital, MDA, Massachusetts General Hospital, MPH, ALS, Muscular dystrophy, NIH, Safety, Pharmaceutical industry

BOSTON and PARIS, Sept. 14, 2023 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the treatment of serious neurological disorders, announced today the initiation of a first-in-human clinical trial evaluating its MyoRegulator® device for the treatment of amyotrophic lateral sclerosis (ALS).

Key Points: 
  • BOSTON and PARIS, Sept. 14, 2023 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the treatment of serious neurological disorders, announced today the initiation of a first-in-human clinical trial evaluating its MyoRegulator® device for the treatment of amyotrophic lateral sclerosis (ALS).
  • This single-center, single-arm, open-label Early Feasibility Study (EFS) is designed to assess the safety and feasibility of the MyoRegulator® device in treating people with ALS, and is being carried out in conjunction with Spaulding Rehabilitation Hospital (Charlestown, MA).
  • “We are tremendously excited to launch this first-in-human trial of MyoRegulator® in ALS,” said Nader Yaghoubi, M.D., Ph.D., Co-Founder and CEO of PathMaker.
  • The MyoRegulator® device based on this technology has been used successfully and safely in two completed clinical trials for post-stroke spasticity.

CENTER FOR PAIN MANAGEMENT WELCOMES DR. JOSHUA WELLINGTON, MD.

Retrieved on: 
Friday, September 1, 2023
Spaulding Rehabilitation Hospital, Boston Children's Hospital, Intrathecal pump, Piriformis syndrome, Beth Israel Deaconess Medical Center, Neck pain, Arthralgia, Interventional pain management, Arthritis, Medical college, Therapy, Twilight anesthesia, ITP, Cancer, North American Neuromodulation Society, American Academy, CRPS, Medicine, MS, Harvard Medical School, Public key certificate, Back pain, Rehabilitation, Medical director, Patient, Physician, Practitioner, Physical medicine and rehabilitation, Fibromyalgia, Hospital, Health, NANS, Chronic pain, Headache, Society, Targeted drug delivery, Injury, Nursing, Dentistry, Pain management, MD

INDIANAPOLIS, Sept. 1, 2023 /PRNewswire/ -- Center for Pain Management, together with American Pain Consortium, a leading network of interventional pain practices, is pleased to announce that Joshua Wellington, MD, MS, has joined their practice and will be seeing patients starting September 5, 2023.

Key Points: 
  • INDIANAPOLIS, Sept. 1, 2023 /PRNewswire/ -- Center for Pain Management, together with American Pain Consortium, a leading network of interventional pain practices, is pleased to announce that Joshua Wellington, MD, MS, has joined their practice and will be seeing patients starting September 5, 2023.
  • He will be joining Center for Pain Management to lead the Targeted Drug Delivery program, which will expand patient access to quality care for Intrathecal Pump (ITP) implants.
  • Center for Pain Management, supported by American Pain Consortium, proudly serves Indiana with 7 clinics and 4 Ambulatory Surgery Centers statewide and has been treating a wide range of acute and chronic pain conditions since 1993.
  • The physicians specialize in back pain, neck pain, headache, and joint pain resulting from injuries, arthritis, cancer, fibromyalgia, failed back surgery, Complex Regional Pain Syndromes (CRPS), and other disorders.

MedRhythms Announces FDA Listing of InTandem™ (MR-001) to Improve Walking and Ambulation in Adults with Chronic Stroke

Retrieved on: 
Thursday, July 6, 2023
Spaulding Rehabilitation Hospital, Survivor, Music, Partnership, Health, Centers for Disease Control and Prevention timeline, Brain, Quality, Translation, CDC, Incidence, Walking, RAS, Patient, Entrepreneurship, Ageing, Regulation, FDA, Regulation of tobacco by the U.S. Food and Drug Administration, Food, Medical device, Pharmaceutical industry, Stroke

PORTLAND, Maine, July 6, 2023 /PRNewswire/ -- MedRhythms today announced that MR-001, the company's evidence-based neurorehabilitation system to improve walking and ambulation in adults with chronic stroke walking deficits, has been listed as a Class II medical device with the U.S. Food and Drug Administration (FDA). The system delivers an intervention based on the principle of Rhythmic Auditory Stimulation (RAS), a well-researched clinical intervention utilizing the mechanism of auditory-motor entrainment, through which the motor and auditory systems in the brain subconsciously synchronize to an external cue, such as music.

Key Points: 
  • MedRhythms also unveiled the brand name for MR-001: InTandem™.
  • The InTandem name reflects both the synchronization inherent in the device's mechanism of action and the partnership formed between patient and device.
  • More than half of stroke survivors aged 65 and older experience reduced mobility, and stroke has become a leading cause of long-term disability.
  • InTandem, which is designed to be used independently by a patient in a home setting, received Breakthrough Device Designation from the FDA in 2020.

Praxis Spinal Cord Institute Adds Five Leaders to Board

Retrieved on: 
Tuesday, June 27, 2023
Spaulding Rehabilitation Hospital, Emergency medicine, Tetraplegia, Disability, Physician, Praxis, Quality of life, Woman, MetroHealth, Boston, Research, CWRU, Person, Translation, Science, Pan American Games, Paralysis, Organization, Boston Police Department, EMS, Mattel, Medical director, Admission, School, Surgeon, MA, Foothills Medical Centre, SCI, Cumming School of Medicine, Chair, Medical device, Management, Paralympic Games, Medicine

Vancouver, BC, June 27, 2023 (GLOBE NEWSWIRE) -- VANCOUVER, BC – June 27, 2023 – The appointment of five new members to the Praxis Spinal Cord Institute Board of Directors brings outstanding experience in advocacy, clinical research, communications and governance to the board.

Key Points: 
  • Vancouver, BC, June 27, 2023 (GLOBE NEWSWIRE) -- VANCOUVER, BC – June 27, 2023 – The appointment of five new members to the Praxis Spinal Cord Institute Board of Directors brings outstanding experience in advocacy, clinical research, communications and governance to the board.
  • Their oversight and experience strengthens our impact, focusing our unique Praxis model on engaging with people with lived experience of spinal cord injury (SCI).
  • Praxis is a Vancouver, BC-based not-for-profit organization that leads global collaboration in spinal cord injury research, innovation, and care.
  • She is currently the Director of the Northeast Ohio Regional Spinal Cord Injury Model System of Care, and was a co-founder and the inaugural President of the North American Spinal Cord Injury Consortium.

New spinal cord stimulation clinical trial gives hope for people living with spinal cord injuries

Retrieved on: 
Tuesday, April 11, 2023
Spaulding Rehabilitation Hospital, Spinal cord stimulator, Partnership, Tetraplegia, Spinal cord, Finger, Quality of life, Research, Rehabilitation, Harvard University, Paralysis, Mount Sinai Hospital, Marquette University, Patient, FDA, Skin, Safety, Medical device, Health insurance

The ASPIRE™ clinical trial will test ExaStim® Therapy to test whether non-invasive spinal cord neuromodulation therapy can increase the quality of life for people living with a spinal cord injury.

Key Points: 
  • The ASPIRE™ clinical trial will test ExaStim® Therapy to test whether non-invasive spinal cord neuromodulation therapy can increase the quality of life for people living with a spinal cord injury.
  • ANEUVO® also has a partnership with Neuroworx of Salt Lake City, which enrolled its first patient in the ASPIRE study last month.
  • “Making life better for people living with spinal cord injuries is the motivating force behind ANEUVO’s work.
  • It uses electric impulses to stimulate the spinal cord to send messages to the patient's upper body.

Wyss Institute’s Lab-on-a-Molecule Drug Discovery Project Receives Funding from Northpond Labs

Retrieved on: 
Tuesday, April 4, 2023
Molecule, CFA, Boston University, Associate, Protein, Hospital, Patient, Wyss Institute, Environment, Laboratory, Disease, Heart, University, Pediatrics, Therapy, Research, Innovation, Drug discovery, Massachusetts General Hospital, Spaulding Rehabilitation Hospital, Tufts University, DNA, Harvard University, MIT, Massachusetts Institute of Technology, Wyss, Berlin, Wyss Institute for Biologically Inspired Engineering, Biochemistry, Partnership, Beth Israel Deaconess Medical Center, INSERT, Woman, RNA, Priscilla Chan, Harvard Medical School, Molecular medicine, Biological engineering, Science, Pharmacology, Medtech, Pharmaceutical industry, Vaccine, Design, Brigham, Engineering

This is the third Wyss project to which Northpond Labs has provided funding and in-kind support to ensure a pathway toward rapid technology commercialization.

Key Points: 
  • This is the third Wyss project to which Northpond Labs has provided funding and in-kind support to ensure a pathway toward rapid technology commercialization.
  • In 2020, the Wyss Institute, Northpond Labs and other collaborating institutions launched the Laboratory for Bioengineering Research and Innovation at the Wyss Institute as part of a research collaboration.
  • In 2022, the Institute, in partnership with Northpond Labs, spun out EnPlusOne Biosciences, an RNA solutions company which started as a controlled enzymatic RNA synthesis project funded by Northpond Labs in 2020.
  • Because of its potential as a next-generation drug discovery technology, the Lab-on-a-Molecule project had already been selected by the Wyss Institute as one of its 2022 Validation Projects .

Tandem Solutions Taps Seasoned Executive to Launch Health Care Advisory Services

Retrieved on: 
Thursday, March 30, 2023
General Health, Consulting, Health, Professional Services, Managed Care, Spaulding Rehabilitation Hospital, Survivor, Executive, Partner, NHL, Rehabilitation, COVID, Thought, Organization, Giovanni Lo Storto, Spaulding, National Hockey League Players' Association, Mass General Brigham, Boston Marathon, Disability studies, Knowledge, Environment, Labour, Management, Nursing

Tandem Solutions, a leading organizational change management company, announced today that David Storto will join the firm as a Senior Health Care Executive Advisor.

Key Points: 
  • Tandem Solutions, a leading organizational change management company, announced today that David Storto will join the firm as a Senior Health Care Executive Advisor.
  • “Health care systems and their leaders are facing unprecedented challenges, while consumers often find themselves caught in a perplexing maze in their efforts to find the right care.
  • “Tandem Solutions supports the success of a variety of organizations through its consulting, leadership development and coaching services.
  • Tandem Solutions and their clients will be well served by him.”
    Storto will be concluding his work at Tufts Medicine at the end of April and will assume his responsibilities at Tandem Solutions at the beginning of June.

MedRhythms Announces Positive Topline Results from Pivotal Trial in Chronic Stroke

Retrieved on: 
Tuesday, January 17, 2023
Disease, Multiple sclerosis, Parkinson's disease, Entrepreneurship, University, Stroke, Biogen, Spaulding Rehabilitation Hospital, University of North Carolina at Chapel Hill, Area studies, Patient, Research, Kessler Foundation, Walking, Chapel Hill, Survivor, Medical imaging, Pharmaceutical industry

PORTLAND, Maine, Jan. 17, 2023 /PRNewswire/ -- MedRhythms announced today that the company's pivotal trial for MR-001, a novel digital intervention in development to treat gait deficits in chronic stroke, was successfully completed and met its primary endpoint.

Key Points: 
  • PORTLAND, Maine, Jan. 17, 2023 /PRNewswire/ -- MedRhythms announced today that the company's pivotal trial for MR-001, a novel digital intervention in development to treat gait deficits in chronic stroke, was successfully completed and met its primary endpoint.
  • "The topline results from our pivotal trial in chronic stroke suggest that our product can help address this unmet need to improve walking.
  • The trial included adult chronic stroke survivors who participated in thirty-minute sessions three times per week over a five-week intervention period.
  • MR-001, in development to treat chronic stroke gait deficits, is anticipated to be the first product the company brings to market.

American College of Lifestyle Medicine Names Award-Winning Harvard Medical School Faculty Member and Author Dr. Beth Frates 2022-24 President

Retrieved on: 
Thursday, December 15, 2022
Degenerative disease, Physician, Certification, Mass, Disease management, Conditional sentence, American College, Path, Wellness, Research, Spaulding Rehabilitation Hospital, Patient, Prevalence, Harvard Extension School, FACC, Massachusetts General Hospital, Curriculum, Stroke, MS, Medicine, Type 2 diabetes, Obesity, Lifestyle medicine, ACLM, Hospital, Health, Harvard Medical School, History of Harvard Extension School, Pharmaceutical industry, Dentistry, MD

ST. LOUIS, Dec. 15, 2022 /PRNewswire-PRWeb/ -- The American College of Lifestyle Medicine (ACLM) has announced the transition of Beth Frates, MD, FACLM, DipABLM, an assistant clinical professor at Harvard Medical School, award winning teacher and author, from president-elect to a two-year term as president of the medical professional association that represents more than 9,000 physicians and other health professionals.

Key Points: 
  • Beth Frates, MD, FACLM, DipABLM, Harvard Medical School faculty, author, trained physiatrist and health and wellness coach, will lead the 9,000-member organization.
  • ACLM is the only medical professional organization that educates, equips, and supports certification of physicians and other clinicians in lifestyle medicine.
  • In 2008, she started the first Lifestyle Medicine Interest Group at Harvard Medical School and later developed and taught the first lifestyle medicine curriculum at the Harvard Extension School, where it remains one of the most well-received courses offered at the school.
  • The American College of Lifestyle Medicine is the nation's medical professional society advancing lifestyle medicine as the foundation for a redesigned, value-based and equitable healthcare delivery system, leading to whole person health.

Spaulding Rehabilitation Hospital and Highland Instruments, Inc., Jointly Announce Use of Integrated Motion Analysis Suite as Part of a NIH Funded Parkinson's Disease Trial

Retrieved on: 
Thursday, November 17, 2022
Doctor of Philosophy, MPH, Physical medicine and rehabilitation, Neurology, Movement, Rehabilitation, Stroke, Movement disorders, Low back pain, Principal investigator, Mortality, MD, MMSc, Parkinson's disease, Master of Education, Spaulding Rehabilitation Hospital, National Institutes of Health, Mass, Research, MIT, Harvard Medical School, Social Security, RCT, Patient, NIH, Unified Parkinson's disease rating scale, SBIR, Clinical trial, Disability, News, Diagnosis, National Institute of Neurological Disorders and Stroke, U.S. News & World Report, Pharmaceutical industry, Medical imaging, PD, Disease

The IMAS has been designed to objectively assess patient kinematics during motor exams with less variability than made during typical motor exams.

Key Points: 
  • The IMAS has been designed to objectively assess patient kinematics during motor exams with less variability than made during typical motor exams.
  • Ultimately, the IMAS system is also being explored as a tool to optimize patient therapy, such as the delivery of neurostimulation dose.
  • The Spaulding Rehabilitation Hospital is a 132-bed rehabilitation teaching hospital located in Boston, MA.
  • It is the official teaching hospital for Harvard Medical School's Department of Physical Medicine and Rehabilitation and the main campus of the Spaulding Rehabilitation Network.